CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $609,000 | +134.2% | 78,821 | +124.0% | 0.00% | – |
| Q3 2019 | $260,000 | -50.3% | 35,182 | -24.5% | 0.00% | -100.0% |
| Q2 2019 | $523,000 | +4.4% | 46,582 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $501,000 | -45.1% | 46,582 | -23.0% | 0.00% | -50.0% |
| Q4 2018 | $913,000 | -23.9% | 60,482 | -6.8% | 0.00% | 0.0% |
| Q3 2018 | $1,200,000 | +11.2% | 64,882 | +37.5% | 0.00% | 0.0% |
| Q2 2018 | $1,079,000 | -12.8% | 47,200 | +8.5% | 0.00% | 0.0% |
| Q1 2018 | $1,238,000 | – | 43,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,230,898 | $40,535,000 | 5.15% |
| Opaleye Management Inc. | 450,000 | $8,176,000 | 2.89% |
| EcoR1 Capital, LLC | 829,771 | $15,077,000 | 2.01% |
| Perceptive Advisors | 2,780,762 | $50,526,000 | 0.96% |
| Casdin Capital, LLC | 177,500 | $3,225,000 | 0.91% |
| Iguana Healthcare Management, LLC | 140,000 | $2,544,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 756,822 | $13,751,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $3,816,000 | 0.54% |
| HAMILTON LANE ADVISORS LLC | 28,346 | $515,000 | 0.35% |
| Tekla Capital Management LLC | 530,092 | $9,632,000 | 0.34% |